| Aspire Indiana Health Inc. | |
|
6775 W State Road 32 Anderson IN 46011-8765 | |
| (765) 534-4351 | |
| Not Available |
| Full Name | Aspire Indiana Health Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 6775 W State Road 32, Anderson, Indiana |
| Authorized Official Name and Position | Timothy D Crockett (CFO) |
| Authorized Official Contact | 3175870505 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aspire Indiana Health Inc. 9615 E 148th St Ste 1 Noblesville IN 46060-4371 Ph: () - | Aspire Indiana Health Inc. 6775 W State Road 32 Anderson IN 46011-8765 Ph: (765) 534-4351 |
| NPI Number | 1548779465 |
|---|---|
| Provider Enumeration Date | 09/22/2017 |
| Last Update Date | 11/03/2023 |
| Medicare PECOS PAC ID | 8921314196 |
|---|---|
| Medicare Enrollment ID | O20171002003622 |
News Archive
GlobalPost reports on Cuba's medical outreach to Africa, writing, "A generation ago, Fidel Castro sent Cuban soldiers to intervene in African civil conflicts and fight the Cold War against U.S. proxies. Now, Cuba's doctors are fanning out across the continent as the island expands its role in administering medical services to some of the world's most ailing countries."
Researchers from Aarhus University and Aarhus University Hospital replace sick intestinal bacteria with intestinal bacteria from healthy donors in a treatment intended to help patients with cirrhosis of the liver. The Novo Nordisk Foundation supports the project with just over DKK 13 million.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.
UBC researchers have developed a data science method that analyzes how easily citizens can access hospitals and walk-in health clinics - and it's a tool that could eventually help city planners and policymakers build smarter, more equitable cities.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548779465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
GlobalPost reports on Cuba's medical outreach to Africa, writing, "A generation ago, Fidel Castro sent Cuban soldiers to intervene in African civil conflicts and fight the Cold War against U.S. proxies. Now, Cuba's doctors are fanning out across the continent as the island expands its role in administering medical services to some of the world's most ailing countries."
Researchers from Aarhus University and Aarhus University Hospital replace sick intestinal bacteria with intestinal bacteria from healthy donors in a treatment intended to help patients with cirrhosis of the liver. The Novo Nordisk Foundation supports the project with just over DKK 13 million.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.
UBC researchers have developed a data science method that analyzes how easily citizens can access hospitals and walk-in health clinics - and it's a tool that could eventually help city planners and policymakers build smarter, more equitable cities.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
› Verified 6 days ago
Anderson Family Health Specialists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 Medical Arts Blvd, Suite 100, Anderson, IN 46011 Phone: 765-298-5700 Fax: 765-298-4913 | |
Five J Woodall Medical Director Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 299 E 360 N, Anderson, IN 46012 Phone: 765-642-8446 Fax: 765-642-7934 | |
Bridges Campbell & Woodall Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1302 S Madison Ave, Anderson, IN 46016 Phone: 765-644-3673 Fax: 765-644-3680 | |
Craig Groninger Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-1851 Fax: 765-642-3756 | |
United Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 417 W 38th St, Anderson, IN 46013 Phone: 765-400-0380 Fax: 765-400-0381 | |
Caesars Health Center Hoosier Park Anderson Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4500 Dan Patch Cir, Anderson, IN 46013 Phone: 765-609-4711 Fax: 765-609-4713 | |
Indiana Standardbred Association Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3029 E 41st St, Anderson, IN 46013 Phone: 317-621-1230 |